<DOC>
	<DOC>NCT00530946</DOC>
	<brief_summary>To assess the changes in the trough Systolic Blood Pressure (SBP) and the percent changes in Low Density Lipoprotein-Cholesterol (LDL-C) from baseline at Week 8 in the treatment period</brief_summary>
	<brief_title>A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Amlodipine, atorvastatin drug combination</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>The outpatient with concurrent hypertension and hyperLDLcholesterolemia is a male or female &gt;=20 to &lt;80 years of age at Visit 1. The SBP at Visit 4 (Week 1) and Visit 5 (Week 0) is continuously SBP &gt;=140 mmHg and &lt;180 mmHg, LDLC &gt;=140 mg/dL and &lt;250 mg/dL at Visit 3 (Week 2) and 4 (Week 1). Subjects who had experienced the following coronary artery disease within the past 3 months. Myocardial infarction Receiving PCI（percutaneous coronary intervention）or CABG (coronary artery bypass grafting) Any clinically meaningful valvular disease Subjects with a history of cerebrovascular diseases such as stroke or transient ischemic attack within the past 3 months.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>